Pds Biotechnology Corp (PDSB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,120 | -9,989 | -4,469 | -12,200 | -9,038 |
| Depreciation Amortization | 118 | 77 | 36 | 60 | 32 |
| Accounts payable and accrued liabilities | -126 | -1,203 | -761 | N/A | 705 |
| Other Working Capital | 1,557 | -1,478 | -308 | 1,690 | 1,327 |
| Other Operating Activity | 3,601 | 2,622 | 1,236 | 740 | 144 |
| Operating Cash Flow | $-14,970 | $-9,971 | $-4,265 | $-9,710 | $-6,831 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -799 | -447 | -86 | -880 | -265 |
| Investing Cash Flow | $-799 | $-447 | $-86 | $-880 | $-265 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 3,000 | 3,000 | 3,000 | N/A | 3,000 |
| Other Financing Activity | 51,920 | 52,154 | -82 | 16,470 | -956 |
| Financing Cash Flow | $54,920 | $55,154 | $2,918 | $16,470 | $2,044 |
| Beginning Cash Position | 13,729 | 13,729 | 13,729 | 7,850 | 7,858 |
| End Cash Position | 52,880 | 58,465 | 12,296 | 13,720 | 2,806 |
| Net Cash Flow | $39,151 | $44,736 | $-1,433 | $5,870 | $-5,052 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,970 | -9,971 | -4,265 | -9,710 | -6,831 |
| Capital Expenditure | -799 | -447 | -86 | N/A | -265 |
| Free Cash Flow | -15,769 | -10,418 | -4,351 | -9,710 | -7,096 |